OptimizeRx CorporationOPRXNASDAQ
Loading
EBITDA as a percentage of revenue
5Y CAGR
+58.6%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
10x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 14.98% | +255.1% |
| 2024 | -9.66% | +67.6% |
| 2023 | -29.79% | -97.6% |
| 2022 | -15.08% | -497.3% |
| 2021 | 3.80% | +154.1% |
| 2020 | 1.49% | +124.3% |
| 2019 | -6.14% | -205.3% |
| 2018 | 5.83% | +139.2% |
| 2017 | -14.89% | +11.5% |
| 2016 | -16.82% | - |